These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6671927)

  • 21. Susceptibility of Bacteroides fragilis to trimethoprim and sulphamethoxazole.
    Phillips I; Warren C
    Lancet; 1974 May; 1(7862):827-9. PubMed ID: 4132787
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of trimethoprim-sulfamethoxazole in gonococcal infections.
    Austin TW; Holmes KK
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):37-9. PubMed ID: 805648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.
    Close SJ; McBurney CR; Garvin CG; Chen DC; Martin SJ
    Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(3):140-6. PubMed ID: 378572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria.
    Liu T; Wang B; Guo J; Zhou Y; Julius M; Njire M; Cao Y; Wu T; Liu Z; Wang C; Xu Y; Zhang T
    J Microbiol Biotechnol; 2015 Sep; 25(9):1559-67. PubMed ID: 25907064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the in vitro activities of sulfamethoxazole and sulfadiazine combinations with trimethoprim.
    Kuipers JS
    Chemotherapy; 1979; 25(2):77-82. PubMed ID: 446188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression-line analysis of trimethoprim-sulfamethoxazole activity against Neisseria gonorrhoeae.
    Prior RB; Fass RJ; Perkins RL
    Am J Clin Pathol; 1976 Sep; 66(3):605-9. PubMed ID: 822707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of ionizing radiation on the antimicrobial activity of the antibiotics sulfamethoxazole and trimethoprim.
    Sági G; Szabacsi K; Szabó L; Homlok R; Kovács K; Mohácsi-Farkas C; Pillai SD; Takács E; Wojnárovits L
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2018 Jul; 53(8):687-693. PubMed ID: 29485359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents.
    Mengelers MJ; van Klingeren B; van Miert AS
    Am J Vet Res; 1990 Nov; 51(11):1860-4. PubMed ID: 2240813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: Susceptibility of Bacteroides fragilis to co-trimoxazole.
    Okubadejo OA
    Lancet; 1974 May; 1(7865):1061. PubMed ID: 4133750
    [No Abstract]   [Full Text] [Related]  

  • 32. Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.
    Goldstein BP; Ripamonti IF; Bolzoni G; Carniti G; Arioli V
    Antimicrob Agents Chemother; 1979 Dec; 16(6):736-42. PubMed ID: 533255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-trimoxazole sensitivity testing: comparison of separate and combined disk agar diffusion techniques.
    Amyes SG; Telfer Brunton WA
    J Clin Pathol; 1981 Feb; 34(2):199-202. PubMed ID: 7229100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim.
    Grüneberg RN; Emmerson AM
    Eur J Clin Microbiol; 1982 Jun; 1(3):155-8. PubMed ID: 6756907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
    Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
    J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim.
    Riley TV; Digiovanni C; Hoyne GF
    J Antimicrob Chemother; 1987 Jan; 19(1):39-43. PubMed ID: 3494008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid.
    Zervos MJ; Schaberg DR
    Antimicrob Agents Chemother; 1985 Sep; 28(3):446-8. PubMed ID: 3935044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.
    Pelton SI; Shurin PA; Klein JO; Finland M
    Antimicrob Agents Chemother; 1977 Dec; 12(6):649-54. PubMed ID: 303886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination.
    Petersen E
    Trans R Soc Trop Med Hyg; 1987; 81(2):238-41. PubMed ID: 3303480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.